Respiratory Medicine
Volume 104, Issue 10 , Pages 1404-1409 , October 2010

Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challenge

  • Maciej Kupczyk

      Affiliations

    • Department of Internal Medicine, Asthma and Allergy, Medical University of Łódź, Kopcinskiego 22, 90-153 Łódź, Poland
    • Corresponding Author InformationCorresponding author. Tel./fax: +4842 6782129.
    • ,
  • Zofia Kurmanowska

      Affiliations

    • Department of Pneumonology and Allergy, Medical University of Łódź, Poland
    • ,
  • Izabela Kupryś-Lipińska

      Affiliations

    • Department of Internal Medicine, Asthma and Allergy, Medical University of Łódź, Kopcinskiego 22, 90-153 Łódź, Poland
    • ,
  • Małgorzata Bocheńska-Marciniak

      Affiliations

    • Department of Pneumonology and Allergy, Medical University of Łódź, Poland
    • ,
  • Piotr Kuna

      Affiliations

    • Department of Internal Medicine, Asthma and Allergy, Medical University of Łódź, Kopcinskiego 22, 90-153 Łódź, Poland

Received 1 December 2009 ,Accepted 16 April 2010.

References 

  1. Szczeklik A, Sanak M. The broken balance in aspirin hypersensitivity. Eur J Pharmacol. 2006;533:145–155
  2. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. Eur Respir J. 2000;16:432–436
  3. Kupczyk M, Kupryś I, Górski P, Kuna P. Aspirin intolerance and allergy to house dust mites: important factors associated with development of severe asthma. Ann Allergy Asthma Immunol. 2004;92(4):453–458
  4. Jenneck C, Juergens U, Buecheler M, et al. Pathogenesis, diagnosis, and treatment of aspirin intolerance. Ann Allergy Asthma Immunol. 2007;99:13–21
  5. Kupczyk M, Antczak A, Kuprys-Lipinska I, Kuna P. Lipoxin A4 generation is decreased in aspirin-sensitive patients in lysine-aspirin nasal challenge in vivo model. Allergy. 2009;64:1746–1752
  6. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis and management. J Allergy Clin Immunol. 2003;111:913–921
  7. Kupczyk M, Kuprys I, Danilewicz M, et al. Adhesion molecules and their ligands in nasal polyps of aspirin-hypersensitive patients. Ann Allergy Asthma Immunol. 2006 Jan;96(1):105–111
  8. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczynska M, Picado C, et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy. 2007;62(10):1111–1118
  9. Picado C, Ramis I, Rosello J, et al. Release of peptide leukotriene into nasal secretions after local instalation of aspirin in aspirin-sensitive patients. Am Rev Respir Dis. 1992;145:65–69
  10. Milewski M, Mastalerz L, Niżankowska E, et al. Nasal provocation test with lysine-aspirin for diagnosis of aspirin sensitive asthma. J Allergy Clin Immunol. 1998;101:581–586
  11. Greiff L, Meyer P, Svensson C, Persson CG, Andersson M. The “nasal pool”-device for challenge and lavage of the nasal mucosa in children: histamine-induced plasma exudation responses. Pediatr Allergy Immunol. 1997;8(3):137–142
  12. Bousquet PJ, Combescure C, Neukirch F, et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy. 2007;62(4):367–372
  13. Ben-Baruch A, Xu L, Young PR, et al. Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors. C-C CKR1, a receptor for macrophage inflammatory protein-1 alpha/Rantes, is also a functional receptor for MCP3. J Biol Chem. 1995;270:22123–22128
  14. Appay V, Dunbar PR, Cerundolo V, et al. RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregation. International Immunology. 2000;12(8):1173–1182
  15. Pods R, Ross D, van Hulst S, et al. RANTES, eotaxin and eotaxin-2 expression and production in patients with aspirin triad. Allergy. 2003;58(11):1165–1170
  16. Min JW, Jang AS, Park SM, et al. Comparison of plasma eotaxin family level in aspirin-induced and aspirin-tolerant asthma patients. Chest. 2005;128(5):3127–3132
  17. Conroy DM, Williams TJ. Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir Res. 2001;2:150–156
  18. Humbless AA, Conroy DM, Marleau S, et al. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Med. 1997;186:601–612
  19. Planaguma A, Kazani S, Marigowda G, et al. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. Am J Respir Crit Care Med. 2008;178:574–582
  20. Mastalerz L, Sanak M, Gawlewicz-Mroczka A, et al. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity. Thorax. 2008;63:27–34
  21. Mastalerz L, Sanak M, Szczeklik A. Serum interleukin-5 in aspirin-induced asthma. Clin Exp Allergy. 2001;31(7):1036–1040
  22. Borger P, ten Hacken NHT, Vellenga E, et al. Peripheral blood T lymphocytes from asthmatic patients are primed for enhanced expression of interleukin (Il)-4 and Il-5 mRNA: associations with lung function and serum IgE. Clin Exp Allergy. 1999;29:772–779
  23. Sun DI, Joo YH, Auo HJ, et al. Clinical significance of eosinophilic cationic protein levels in nasal secretions of patients with nasal polyposis. Eur Arch Otorhinolaryngol. 2009;266(7):981–986
  24. Sanak M, Pierzchalska M, Bazan-Socha S, Szczeklik A. Enhanced expression of the leukotriene C4 synthase due to overactive transcription of an allelic variant associated with aspirin-induced asthma. Am J Respir Cell Molec Biol. 2000;23:290–296

PII: S0954-6111(10)00196-4

doi: 10.1016/j.rmed.2010.04.017

Respiratory Medicine
Volume 104, Issue 10 , Pages 1404-1409 , October 2010

Article Tools

* Image Usage & Resolution